Immune Activation and Anemia Are Associated with Decreased Quality of Life in Patients with Solid Tumors
Open Access
- 11 October 2020
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 9 (10), 3248
- https://doi.org/10.3390/jcm9103248
Abstract
Anemia often coincides with depression and impaired quality of life (QoL) in cancer patients. Sustained immune activation can lead to the development of anemia. Furthermore, it also may go along with changes in tryptophan and phenylalanine metabolism. The aim of our pilot study was to study the relationship between anemia, immune-mediated changes in amino acid metabolism, and the QoL and mood of cancer patients. Questionnaires to measure QoL and depression were completed by 152 patients with solid tumors. Hemoglobin, parameters of immune activation as well as tryptophan and phenylalanine metabolism were determined in the patients’ sera. Anemic patients (51.7%) presented with higher inflammatory markers, and a higher tryptophan breakdown with lower tryptophan concentrations. They reported an impaired QoL and had higher depression scores. Patients with an impaired QoL (65.8%) also suffered from more fatigue and impaired physical, emotional, and social functioning. They, furthermore, presented with higher concentrations of inflammatory markers (C-reactive protein (CRP) and neopterin) as well as higher tryptophan degradation (in men) and higher phenylalanine concentrations (in women). Sixty-one patients (40.1%) had (mostly mild) depression. In these patients, a higher degree of Th1 immune activation was found. The results of our study suggest that cancer-related anemia goes along with an impaired QoL, which is also associated with immune-mediated disturbances of tryptophan and phenylalanine metabolism.Keywords
This publication has 59 references indexed in Scilit:
- Anxiety and depression after cancer diagnosis: Prevalence rates by cancer type, gender, and ageJournal of Affective Disorders, 2012
- Fatigue in Patients with Lung Cancer Is Related with Accelerated Tryptophan BreakdownPLOS ONE, 2012
- Ineffective erythropoiesis with reduced red blood cell survival in serotonin-deficient miceProceedings of the National Academy of Sciences, 2011
- Immune system to brain signaling: Neuropsychopharmacological implicationsPharmacology & Therapeutics, 2011
- Inflammation-associated depression: From serotonin to kynureninePsychoneuroendocrinology, 2010
- Diminished quality of life in patients with cancer correlates with tryptophan degradationZeitschrift für Krebsforschung und Klinische Onkologie, 2007
- Possible role of cytokine-induced tryptophan degradation in anaemia of inflammationEuropean Journal of Haematology, 2004
- The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in OncologyJNCI Journal of the National Cancer Institute, 1993
- Interferons and indoleamine 2,3-dioxygenase: Role in antimicrobial and antitumor effectsCellular and Molecular Life Sciences, 1989
- Human macrophages degrade tryptophan upon induction by interferon-gammaLife Sciences, 1987